NIKKISO CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,270 JPY | +1.11% |
|
-1.63% | +23.30% |
| Sales 2022 | 177B 1.15B | Sales 2023 | 193B 1.25B | Capitalization | 68.17B 441M |
|---|---|---|---|---|---|
| Net income 2022 | 13.64B 88.22M | Net income 2023 | 9.07B 58.67M | EV / Sales 2022 | 0.58 x |
| Net Debt 2022 | 40.53B 262M | Net Debt 2023 | 48.16B 312M | EV / Sales 2023 | 0.6 x |
| P/E ratio 2022 |
4.87
x | P/E ratio 2023 |
7.52
x | Employees | 8,131 |
| Yield 2022 |
2.63% | Yield 2023 |
-
| Free-Float | 78.1% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +1.11% | ||
| 1 week | -1.63% | ||
| Current month | -1.40% | ||
| 1 month | +3.93% | ||
| 3 months | +20.49% | ||
| 6 months | +35.25% | ||
| Current year | +23.30% |
1 week
1 245.00
1 287.00
1 month
1 216.001 303.00
Current year
1 014.001 303.00
1 year
858.001 303.00
3 years
666.001 303.00
5 years
666.001 508.00
10 years
623.001 557.00
| Managers | Title | Age | Since |
|---|---|---|---|
Toshihiko Kai
PSD | President | 77 | 00-02-29 |
Kazuo Nakatsuru
COO | Chief Operating Officer | - | - |
Kenji Saito
BRD | Director/Board Member | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Toshihiko Kai
PSD | President | 77 | 00-02-29 |
Tsunehisa Suita
BRD | Director/Board Member | 64 | 10-03-31 |
Susumu Koito
BRD | Director/Board Member | 65 | 81-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.05% | 31 M€ | +11.98% | ||
| 0.01% | 18 M€ | +16.15% | - | |
| 0.01% | 144,586 M€ | +14.29% | ||
| 0.01% | 66,066 M€ | +14.30% | - | |
| 0.01% | 20,721 M€ | +13.20% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 1,270 | +1.11% | 83,700 |
| 24-04-17 | 1,256 | -1.02% | 113,400 |
| 24-04-16 | 1,269 | -1.25% | 118,800 |
| 24-04-15 | 1,285 | -0.08% | 86,300 |
| 24-04-12 | 1,286 | -0.39% | 105,900 |
Delayed Quote Japan Exchange, April 18, 2024 at 02:00 am EDT
More quotes
NIKKISO CO.,LTD. is a Japan-based company principally engaged in the manufacture and sale of industrial pumps, precision equipment and blood related products, among others. The Company operates in two business segments. Industrial Business segment conducts industrial business including the manufacture, sale and maintenance of industrial special pumps, as well as liquefied gas & industrial gas related equipment and devices. The Segment is also involved in precision equipment business, aerospace business and deep ultraviolet light emitting diode (LED) business. Medical Business segmentâs products are dialysis-related products including hemodialysis and peritoneal dialysis, such as artificial dialysis machines, dialyzers, blood circuits, and powder-type dialysis agents. The Segment also manufactures, sells and maintains products and medicines related to CRRT (acute blood purification therapy), artificial pancreas devices that manage blood glucose, and energy devices for microwave surgery.
Calendar
2024-05-14
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +23.30% | 537M | |
| +5.24% | 77.94B | |
| +16.80% | 69.42B | |
| +15.05% | 36.14B | |
| +11.19% | 30.52B | |
| +8.90% | 28.18B | |
| +10.00% | 27.28B | |
| +4.61% | 26.67B | |
| +11.88% | 24.22B | |
| +9.62% | 23.29B |
- Stock Market
- Equities
- 6376 Stock
